Literatura académica sobre el tema "BREAST PROGRESSION"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "BREAST PROGRESSION".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "BREAST PROGRESSION"
Arafat, Kholoud, Elham Al Kubaisy, Shahrazad Sulaiman, Sherif M. Karam, Zeina Al Natour, Ahmed H. Hassan y Samir Attoub. "SMARCAD1 in Breast Cancer Progression". Cellular Physiology and Biochemistry 50, n.º 2 (2018): 489–500. http://dx.doi.org/10.1159/000494163.
Texto completoGespach, Christian. "Reciprocity in breast cancer progression". Oncotarget 5, n.º 22 (30 de noviembre de 2014): 10967–68. http://dx.doi.org/10.18632/oncotarget.2853.
Texto completoChen, Yinghua y Olufunmilayo I. Olopade. "MYC in breast tumor progression". Expert Review of Anticancer Therapy 8, n.º 10 (octubre de 2008): 1689–98. http://dx.doi.org/10.1586/14737140.8.10.1689.
Texto completoDalgin, Gul S., Gabriela Alexe, Daniel Scanfeld, Pablo Tamayo, Jill P. Mesirov, Shridar Ganesan, Charles DeLisi y Gyan Bhanot. "Portraits of breast cancer progression". BMC Bioinformatics 8, n.º 1 (2007): 291. http://dx.doi.org/10.1186/1471-2105-8-291.
Texto completoMa, L. "Determinants of Breast Cancer Progression". Science Translational Medicine 6, n.º 243 (2 de julio de 2014): 243fs25. http://dx.doi.org/10.1126/scitranslmed.3009587.
Texto completoSUBRAMANIAN, BALAKRISHNA y DAVID E. AXELROD. "Progression of Heterogeneous Breast Tumors". Journal of Theoretical Biology 210, n.º 1 (mayo de 2001): 107–19. http://dx.doi.org/10.1006/jtbi.2001.2302.
Texto completoKontomanolis, Emmanuel N., Sofia Kalagasidou, Stamatia Pouliliou, Xanthoula Anthoulaki, Nikolaos Georgiou, Valentinos Papamanolis y Zacharias N. Fasoulakis. "The Notch Pathway in Breast Cancer Progression". Scientific World Journal 2018 (8 de julio de 2018): 1–11. http://dx.doi.org/10.1155/2018/2415489.
Texto completoFerreira, Sandra, Nuno Saraiva, Patrícia Rijo y Ana S. Fernandes. "LOXL2 Inhibitors and Breast Cancer Progression". Antioxidants 10, n.º 2 (19 de febrero de 2021): 312. http://dx.doi.org/10.3390/antiox10020312.
Texto completoSkinner, Kristin A., C. Alan Kachel, Raymond Sullivan, Andrew Jones y Soudamini Kurumboor. "Progressive accumulation of DNA methylation with malignant progression in breast tissue". Journal of the American College of Surgeons 199, n.º 3 (septiembre de 2004): 85. http://dx.doi.org/10.1016/j.jamcollsurg.2004.05.184.
Texto completoArtacho-Cordón, Antonia, Francisco Artacho-Cordón, Sandra Ríos-Arrabal, Irene Calvente y María Isabel Núñez. "Tumor microenvironment and breast cancer progression". Cancer Biology & Therapy 13, n.º 1 (enero de 2012): 14–24. http://dx.doi.org/10.4161/cbt.13.1.18869.
Texto completoTesis sobre el tema "BREAST PROGRESSION"
Chuprovska, Yu Ya. "Characteristics of breast cancer progression". Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18208.
Texto completoKinnard, Krista. "Human Tandem Repeats in Breast Cancer Progression". Thesis, The University of Arizona, 2010. http://hdl.handle.net/10150/146036.
Texto completoLopez, Jose Ignacio. "CD44 Attenuates Metastasis During Breast Cancer Progression". Diss., The University of Arizona, 2008. http://hdl.handle.net/10150/193882.
Texto completoPandey, Puspa Raj. "ROLES OF LIPOGENESIS IN BREAST CANCER PROGRESSION". OpenSIUC, 2012. https://opensiuc.lib.siu.edu/dissertations/490.
Texto completoGreen, Margaret. "Prognostic factors in breast and colorectal cancer". Thesis, University of Surrey, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298045.
Texto completoRose, April. "The role of GPNMB in breast tumor progression". Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=96876.
Texto completoLe cancer du sein est le cancer le plus fréquemment diagnostiqué et la seconde cause de mortalité associée au cancer chez les femmes canadiennes. Le développement de métastases est la cause majeure de la morbidité et de la mortalité dûes à cette maladie. Le cancer du sein est une maladie très hétérogène qui peut toutefois être traité par l'utilisation de thérapie ciblée ; toutefois, les thérapies actuellement disponibles ont un effet limité sur la formation des métastases. Dans le but d'identifier de nouveaux médiateurs moléculaires associés à la formation de métastases osseuses dérivées du cancer du sein et qui pourraient être utilisés comme cibles thérapeutiques, nous avons soumis les cellules de carcinome mammaire 4T1 à un processus de sélection in vivo dans des souris Balb/c. Nous avons ainsi isolé des sous-populations de cellules caractérisées par leur agressivité à former des métastases osseuses. L'étude de l'expression génique de ces cellules a mis en évidence que le gène codant pour la Glycoprotéine NMB (GPNMB), aussi connu sous le nom de Ostéoactivine, est très fortement exprimé dans les lignées de cancer du sein métastatiques pour l'os.GPNMB est une protéine de surface transmembranaire de type I qui possède des domaines RGD et PKD extracellulaires ainsi qu'un motif hemITAM de signalisation cytoplasmique et n'avait encore jamais été rapportée comme impliquée dans le cancer du sein.Nous avons démontré que l'expression ectopique de GPNMB était suffisante pour promouvoir la migration et l'invasion de cellules de cancer du sein in vitro ainsi que la formation de métastases in vivo.Par la suite, nous avons analysé les niveaux d'expression des ARNm et de la protéine GPNMB dans des centaines de tumeur du sein humain et avons observé que l'expression de GPNMB corrèle positivement avec un risque accru de présence de métastases ainsi qu'une réduction du temps moyen de survie. Nous avons également démontré que GPNMB est le plus fréquemment exprimé dans des tumeurs mammaires appartenant au sous-type triple négatif pour lequel il n'y a actuellement aucune thérapie ciblée disponible.Par ailleurs, nous montrons pour la première fois que CDX-011, une drogue conjuguée à un anticorps monoclonal reconnaissant GPNMB, était capable, in vitro, d'éradiquer spécifiquement les cellules de cancer du sein exprimant GPNMB ainsi que d'induire une régression tumorale in vivo.Finalement, nous avons déterminé les effets de GPNMB sur la progression des tumeurs primaires et avons observé que GPNMB inhibait l'apoptose des cellules tumorales tout en augmentant l'angiogenèse et la croissance tumorale in vivo. Nous avons démontré que le domaine extracellulaire de GPNMB (ECD) pouvait être clivé de façon protéolytique par ADAM10 et ainsi être libéré de la surface cellulaire des cellules de cancer du sein. Nous avons postulé que la forme extracellulaire clivée (ECD) de GPNMB pourrait être impliquée dans certains des effets pro-angiogénique et avons montré que cet ECD était capable d'induire la migration de cellules endothéliales in vitro.L'ensemble des travaux décrits dans cette thèse implique pour la premier fois est le premier à identifier GPNMB comme médiateur fonctionnel de la croissance du cancer du sein et de ses métastases. Ce travail identifie GPNMB comme une importante cible thérapeutique pour le traitement des patients atteints du cancer du sein.
Perera, Kaluarachchige Upamali Lakshika. "The role of lamellipodin in breast cancer progression". Thesis, King's College London (University of London), 2015. http://kclpure.kcl.ac.uk/portal/en/theses/the-role-of-lamellipodin-in-breast-cancer-progression(0a983ebb-e6e8-43e6-bf91-9258a50849bd).html.
Texto completoZelenko, Zara. "The Role of Hyperinsulinemia in Breast Cancer Progression". Thesis, Icahn School of Medicine at Mount Sinai, 2016. http://pqdtopen.proquest.com/#viewpdf?dispub=10129345.
Texto completoWomen with Type 2 diabetes (T2D) have a 49% increase in breast cancer related mortality compared to women without T2D. Epidemiological studies report that increased endogenous insulin levels and increased insulin receptor (IR) expression are associated with poor survival in breast cancer patients. Therefore, it is essential to investigate the role of endogenous hyperinsulinemia on breast cancer progression. Presented in this thesis are contributions to understanding the effect of insulin in a mouse model of hyperinsulinemia (MKR mouse). First, data is shown that highlights the significant increase in primary MVT-1 tumors and pulmonary metastasis in the MKR mouse compared to Wild Type mice. The studies presented show that the primary tumors from the MKR mice have significantly higher Vimentin protein expression compared to primary tumors from control mice. Next, the studies determine that silencing Vimentin expression in the tumor cells leads to either decreased number of pulmonary metastasis in the hyperinsulinemic mice. The work in this thesis also establishes a novel immunodeficient hyperinsulinemic (Rag/MKR) mouse model that enabled the study of the effects of endogenous insulin on the progression of human cancer cells. The hyperinsulinemia of the Rag/MKR mice promoted a significant increase in tumor growth of MDA-MB-231 and LCC6 cells. The knockdown of the insulin receptor in the LCC6 cells led to primary tumors that were significantly smaller in both the hyperinsulinemic Rag/MKR and Rag/WT control mice compared to the tumors from the LCC6 control cells. Finally, it is shown for the first time that the knockdown of the IR promotes a reversal of the epithelial-mesenchymal phenotype by repressing mesenchymal markers and re-expressing epithelial markers in the LCC6 insulin receptor knockdown tumors. The data presented in this thesis highlight a potential contribution to the understanding of the role of insulin in the setting of hyperinsulinemia and provide potential targets for therapy to improve survival in women with breast cancer and hyperinsulinemia.
Chen, Hsiu-Hsi. "Mathematical models for progression of breast cancer and evaluation of breast cancer screening". Thesis, University of Cambridge, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388263.
Texto completoKarp, Cristina M. "HRPAP20 a novel tumor progression regulator in breast cancer /". Cincinnati, Ohio : University of Cincinnati, 2005. http://www.ohiolink.edu/etd/view.cgi?acc%5Fnum=ucin1108156644.
Texto completoLibros sobre el tema "BREAST PROGRESSION"
1952-, Dickson Robert B. y Lippman Marc E. 1945-, eds. Mammary tumorigenesis and malignant progression: Advances in cellular and molecular biology of breast cancer. Boston: Kluwer Academic Publishers, 1994.
Buscar texto completoYacoub, Ninos. Molecular events involving p27kip1, p53 HER-2/neu, and ER in multistep progression of breast cancer. Ottawa: National Library of Canada, 2000.
Buscar texto completoLippman, Marc E. y Robert B. Dickson. Mammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer. Springer, 2012.
Buscar texto completoBerns, P. M. J. J., Romijn J. C y Schröder F. H, eds. Mechanisms of progression to hormone-independent growth of breast and prostatic cancer. Carnforth, Lancs, UK: Parthenon Pub. Group, 1991.
Buscar texto completoLippman, Marc E. y Robert B. Dickson. Mammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer. Springer, 2012.
Buscar texto completoApple, Sophia K. y Lawrence W. Bassett. Proliferative Lesions and Breast Cancer Histopathology. Editado por Christoph I. Lee, Constance D. Lehman y Lawrence W. Bassett. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190270261.003.0004.
Texto completoMammary Tumorigenesis and Malignant Progression: Advances in Cellular and Molecular Biology of Breast Cancer (Cancer Treatment and Research). Springer, 1994.
Buscar texto completoHopko, Derek R., Crystal C. McIndoo, Michael Gawrysiak y Stevie Grassetti. Psychosocial Interventions for Depressed Breast Cancer Patients. Editado por C. Steven Richards y Michael W. O'Hara. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199797004.013.004.
Texto completoRodriguez-Rincon, Daniela, Brandi Leach y Catriona Manville. Understanding the societal impact of treatment of early breast cancer: What are the non-clinical outcomes associated with disease progression? RAND Corporation, 2019. http://dx.doi.org/10.7249/rr3010.1.
Texto completoElmore, Natasha, Sarah King, Josephine Exley, Daniela Rodriguez-Rincon, Jody Larkin, Molly Morgan Jones y Catriona Manville. Findings from a systematic review to explore the patient and societal impacts of disease progression in women who were treated for early breast cancer: Implications for future research, policy and practice. RAND Corporation, 2019. http://dx.doi.org/10.7249/rr3010.3.
Texto completoCapítulos de libros sobre el tema "BREAST PROGRESSION"
Band, Vimla y Ruth Sager. "Tumor Progression in Breast Cancer". En Neoplastic Transformation in Human Cell Culture, 169–78. Totowa, NJ: Humana Press, 1991. http://dx.doi.org/10.1007/978-1-4612-0411-4_18.
Texto completoCallahan, Robert. "Oncogenes and Breast Cancer Progression". En Boundaries between Promotion and Progression during Carcinogenesis, 143–56. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-5994-4_13.
Texto completoPietras, Richard J. y Mark D. Pegram. "Oncogene Activation and Breast Cancer Progression". En Endocrinology of Breast Cancer, 133–53. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-699-7_10.
Texto completoKern, Francis G. "The Role of Fibroblast Growth Factors in Breast Cancer Pathogenesis and Progression". En Breast Cancer, 59–93. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-456-6_3.
Texto completoShukla, Samriddhi y Syed Musthapa Meeran. "Epigenetic Factors in Breast Cancer Progression". En Breast Cancer Metastasis and Drug Resistance, 341–65. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5647-6_19.
Texto completoLin, Elaine Y. y Jeffrey W. Pollard. "Macrophages: Modulators of Breast Cancer Progression". En Novartis Foundation Symposia, 158–72. Chichester, UK: John Wiley & Sons, Ltd, 2008. http://dx.doi.org/10.1002/0470856734.ch12.
Texto completoGul, Hira, Iqra y Nosheen Masood. "Early-Stage Progression of Breast Cancer". En Breast Cancer: From Bench to Personalized Medicine, 113–23. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-0197-3_6.
Texto completovon Minckwitz, Gunter y Cristina Pirvulescu. "Treatment with Trastuzumab Beyond Progression". En Drugs for HER-2-positive Breast Cancer, 61–71. Basel: Springer Basel, 2010. http://dx.doi.org/10.1007/978-3-0346-0094-1_4.
Texto completoCardiff, R. D., D. W. Morris, L. J. T. Young y R. Strange. "MuMTV Genotype, Protoneoplasia, and Tumor Progression". En Breast Cancer: Origins, Detection, and Treatment, 156–66. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4613-2309-9_12.
Texto completoSameni, Mansoureh, Stefanie R. Mullins, Kamiar Moin, Bonnie F. Sloane y Kingsley Osuala. "Modeling Breast Cancer Progression in 4-D". En Breast Cancer Metastasis and Drug Resistance, 177–88. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5647-6_10.
Texto completoActas de conferencias sobre el tema "BREAST PROGRESSION"
Snider, Kara E., Hormoz Ehya, Jose Russo y Sandra V. Fernandez. "Abstract 75:NRG1andRARβhypermethylation in breast cancer progression". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-75.
Texto completoSauter, ER, W. Qin y S. Dasgupta. "Abstract P1-04-01: Breast milk exosomes promote breast cancer progression". En Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p1-04-01.
Texto completoTaghipour, S., D. Banjevic, N. Montgomery y A. K. S. Jardine. "Modeling breast cancer progression and evaluating screening policies". En 2013 Annual Reliability and Maintainability Symposium (RAMS). IEEE, 2013. http://dx.doi.org/10.1109/rams.2013.6517766.
Texto completoPolyak, Kornelia. "Abstract IA005: Immune escape during breast tumor progression". En Abstracts: AACR Virtual Special Conference: The Evolving Tumor Microenvironment in Cancer Progression: Mechanisms and Emerging Therapeutic Opportunities; in association with the Tumor Microenvironment (TME) Working Group; January 11-12, 2021. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.tme21-ia005.
Texto completoMcAllister, Sandra S. "Abstract IA07: Systemic regulation of breast cancer progression". En Abstracts: AACR Special Conference on Tumor Metastasis; November 30-December 3, 2015; Austin, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.tummet15-ia07.
Texto completoMardis, Elaine R. "Abstract IA04: Genomic studies of breast cancer progression". En Abstracts: AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications - October 3-6, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1557-3125.advbc-ia04.
Texto completoChen, Cindy X., Han Sang Park y Adam Wax. "Breast Cell Cancer Progression Characterization Through Holographic Cytometry". En Novel Techniques in Microscopy. Washington, D.C.: OSA, 2021. http://dx.doi.org/10.1364/ntm.2021.nth2c.3.
Texto completoZhou, W., AA Muggerud, P. Vu, EU Due, T. Sørlie, A. Børresen-Dale, F. Wärnberg y A. Langerød. "TP53mutation is an early event in breast cancer progression." En CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-1047.
Texto completoMan, Y., Z. Zhang, C. Wang, L. Gao y X. Zhang. "CAPC expression correlates with breast tumor progression and invasion." En CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-4044.
Texto completoPhoenix, KN, F. Vumbaca y KP Claffey. "Effective metabolic intervention of breast cancer progression and metastasis." En CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-6024.
Texto completoInformes sobre el tema "BREAST PROGRESSION"
Galaktionov, Konstantin. MicroRNA and Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2007. http://dx.doi.org/10.21236/ada480199.
Texto completoLin, Chen-Yong. Matriptase Activation in Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, junio de 2005. http://dx.doi.org/10.21236/ada439289.
Texto completoLin, Chen-Yong. Matriptase Activation in Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, junio de 2004. http://dx.doi.org/10.21236/ada427164.
Texto completoLin, Chen-Yong. Matriptase Activation in Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, junio de 2003. http://dx.doi.org/10.21236/ada417787.
Texto completoMcLeskey, Sandra W. Stromal Components of Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, julio de 1998. http://dx.doi.org/10.21236/ada354318.
Texto completoSerra, Rosa y Andra Frost. Primary Cilia in Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, junio de 2010. http://dx.doi.org/10.21236/ada601708.
Texto completoGerald, William L. Gene Expression Analysis of Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, julio de 2005. http://dx.doi.org/10.21236/ada437751.
Texto completoVlodavsky, Israel. Involvement of Heparanase in Breast Carcinoma Progression. Fort Belvoir, VA: Defense Technical Information Center, junio de 2001. http://dx.doi.org/10.21236/ada395693.
Texto completoZhang, Lurong. Membrane-Bound Hyaluronidase in Breast Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2001. http://dx.doi.org/10.21236/ada398227.
Texto completoVlodavsky, Israel, Yael Friedmann y Tamar Peretz. Involvement of Heparanase in Breast Carcinoma Progression. Fort Belvoir, VA: Defense Technical Information Center, junio de 2002. http://dx.doi.org/10.21236/ada407484.
Texto completo